ILMN - Illumina, Inc. Stock Analysis

DATE	TYPE	RATIO
2008-09-23	Forward	2:1

DATE

TYPE

RATIO

2008-09-23

Forward

2:1

Latest News

PRNEWSWIRE · OCT 8, 2026

Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026

SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2026 following the close of market on Thursday, October 29, 2026. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

READ ARTICLE

EARLIER COVERAGE

PRNEWSWIRE · OCT 8, 2026

Illumina releases SpliceAI2 to help advance rare disease research

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina's genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic variation. SpliceAI2 helps researchers identify disease-relevant splice variants that otherwise may go unnoticed.

READ ARTICLE

DEFENSE WORLD · OCT 7, 2026

Illumina, Inc. (NASDAQ:ILMN) Stock Now Rated “Hold” by Sell-Side Analysts

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) has earned a consensus rating of "Hold" from the eighteen brokerages that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and ten have assigned a buy recommendation to the company. The

READ ARTICLE

DEFENSE WORLD · OCT 5, 2026

Argent Capital Management LLC Purchases New Holdings in Illumina, Inc. $ILMN

Argent Capital Management LLC purchased a new position in shares of Illumina, Inc. (NASDAQ: ILMN) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 14,634 shares of the life sciences company's stock, valued at approximately $4,005,000. Other hedge funds also

READ ARTICLE

DEFENSE WORLD · OCT 1, 2026

Illumina (NASDAQ:ILMN) Reaches New 52-Week High – What’s Next?

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) shares hit a new 52-week high on Tuesday. The company traded as high as $278.99 and last traded at $273.1990, with a volume of 227282 shares trading hands. The stock had previously closed at $271.90. Analyst Upgrades and Downgrades A number of analysts have recently commented on the

READ ARTICLE